Kruger J, Behrangi N, Schliep D, Heinig L, Vankriekelsvenne E, Wigger N
Sci Rep. 2025; 15(1):4216.
PMID: 39905182
PMC: 11794462.
DOI: 10.1038/s41598-025-87825-8.
de la Fuente A, Dittmer M, Heesbeen E, de la Vega Gallardo N, White J, Young A
Nat Commun. 2024; 15(1):1870.
PMID: 38467607
PMC: 10928230.
DOI: 10.1038/s41467-024-45742-w.
Yang S, Chen D, Xie L, Zou X, Xiao Y, Rao L
Sci China Life Sci. 2023; 66(11):2614-2628.
PMID: 37428306
DOI: 10.1007/s11427-022-2345-2.
Moyon S, Holloman M, Salzer J
Front Cell Neurosci. 2023; 17:1114781.
PMID: 36779010
PMC: 9909070.
DOI: 10.3389/fncel.2023.1114781.
Nguyen J, Chauhan A
Neural Regen Res. 2022; 18(7):1397-1403.
PMID: 36571333
PMC: 10075112.
DOI: 10.4103/1673-5374.360345.
Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery.
van Schaik P, Zuhorn I, Baron W
Int J Mol Sci. 2022; 23(15).
PMID: 35955549
PMC: 9368816.
DOI: 10.3390/ijms23158418.
Diversity of Reactive Astrogliosis in CNS Pathology: Heterogeneity or Plasticity?.
Moulson A, Squair J, Franklin R, Tetzlaff W, Assinck P
Front Cell Neurosci. 2021; 15:703810.
PMID: 34381334
PMC: 8349991.
DOI: 10.3389/fncel.2021.703810.
Complement C6 deficiency exacerbates pathophysiology after spinal cord injury.
Su D, Hooshmand M, Galvan M, Nishi R, Cummings B, Anderson A
Sci Rep. 2020; 10(1):19500.
PMID: 33177623
PMC: 7659012.
DOI: 10.1038/s41598-020-76441-3.
Changes in the Oligodendrocyte Progenitor Cell Proteome with Ageing.
de la Fuente A, Queiroz R, Ghosh T, McMurran C, Cubillos J, Bergles D
Mol Cell Proteomics. 2020; 19(8):1281-1302.
PMID: 32434922
PMC: 8015006.
DOI: 10.1074/mcp.RA120.002102.
Remyelination and ageing: Reversing the ravages of time.
Neumann B, Segel M, Chalut K, Franklin R
Mult Scler. 2019; 25(14):1835-1841.
PMID: 31687878
PMC: 7682531.
DOI: 10.1177/1352458519884006.
Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.
Lombardi M, Parolisi R, Scaroni F, Bonfanti E, Gualerzi A, Gabrielli M
Acta Neuropathol. 2019; 138(6):987-1012.
PMID: 31363836
PMC: 6851224.
DOI: 10.1007/s00401-019-02049-1.
Regenerating CNS myelin - from mechanisms to experimental medicines.
Franklin R, ffrench-Constant C
Nat Rev Neurosci. 2017; 18(12):753-769.
PMID: 29142295
DOI: 10.1038/nrn.2017.136.
Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.
de la Fuente A, Errea O, van Wijngaarden P, Gonzalez G, Kerninon C, Jarjour A
J Cell Biol. 2015; 211(5):975-85.
PMID: 26644513
PMC: 4674280.
DOI: 10.1083/jcb.201505119.
Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination.
Garea Rodriguez E, Wegner C, Kreutzfeldt M, Neid K, Thal D, Jurgens T
Acta Neuropathol. 2014; 128(2):231-46.
PMID: 24563023
PMC: 4102825.
DOI: 10.1007/s00401-014-1260-8.
Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis.
Hampton D, Serio A, Pryce G, Al-Izki S, Franklin R, Giovannoni G
Acta Neuropathol Commun. 2013; 1:84.
PMID: 24364862
PMC: 3895761.
DOI: 10.1186/2051-5960-1-84.
Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS.
Merson T, Binder M, Kilpatrick T
Neuromolecular Med. 2010; 12(2):99-132.
PMID: 20411441
DOI: 10.1007/s12017-010-8112-z.
Epigenetic mechanisms facilitating oligodendrocyte development, maturation, and aging.
Copray S, Huynh J, Sher F, Casaccia-Bonnefil P, Boddeke E
Glia. 2009; 57(15):1579-87.
PMID: 19373939
PMC: 2760733.
DOI: 10.1002/glia.20881.
